BEE Stock Overview
Bee Vectoring Technologies International Inc. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Bee Vectoring Technologies International Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.01 |
| 52 Week High | CA$0.06 |
| 52 Week Low | CA$0.005 |
| Beta | 0.50 |
| 11 Month Change | 0% |
| 3 Month Change | -50.00% |
| 1 Year Change | -83.33% |
| 33 Year Change | -96.36% |
| 5 Year Change | -97.44% |
| Change since IPO | -96.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| BEE | CA Chemicals | CA Market | |
|---|---|---|---|
| 7D | 100.0% | -1.3% | 0.7% |
| 1Y | -83.3% | -11.6% | 21.7% |
Return vs Industry: BEE underperformed the Canadian Chemicals industry which returned -13.2% over the past year.
Return vs Market: BEE underperformed the Canadian Market which returned 21.4% over the past year.
Price Volatility
| BEE volatility | |
|---|---|
| BEE Average Weekly Movement | 59.3% |
| Chemicals Industry Average Movement | 6.7% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: BEE's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: BEE's weekly volatility has increased from 45% to 59% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Ashish Malik | www.beevt.com |
Bee Vectoring Technologies International Inc. focuses on the control of pests, and enhancement of crops and ornamentals through the biological controls in a variety of application processes in the United States. The company’s solutions comprise the Hive & Bees, an inoculum dispenser system; Vectorpak, a removable, easy-to-use tray that contain Vectorite, a specially formulated patented powder made from various natural materials; active ingredients, such as BVT-CR7, an organic strain of a natural occurring endophytic fungus; and pollen distribution systems. Its patented and patent pending technology utilizes bees as natural delivery mechanisms for a variety of powdered mixtures comprising organic compounds, used products which inhibit, and eliminate common crop diseases.
Bee Vectoring Technologies International Inc. Fundamentals Summary
| BEE fundamental statistics | |
|---|---|
| Market cap | CA$1.04m |
| Earnings (TTM) | -CA$4.63m |
| Revenue (TTM) | CA$115.21k |
18.0x
P/S Ratio-0.4x
P/E RatioIs BEE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BEE income statement (TTM) | |
|---|---|
| Revenue | CA$115.21k |
| Cost of Revenue | CA$12.82k |
| Gross Profit | CA$102.39k |
| Other Expenses | CA$4.73m |
| Earnings | -CA$4.63m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.022 |
| Gross Margin | 88.87% |
| Net Profit Margin | -4,018.68% |
| Debt/Equity Ratio | 56.1% |
How did BEE perform over the long term?
See historical performance and comparison